MustGrow Biologics Corp. (FRA:0C0)
Germany · Delayed Price · Currency is EUR 0.4250
-0.0560 (-11.64%)
At close: Jan 30, 2026
MustGrow Biologics Market Cap
MustGrow Biologics has a market cap or net worth of €28.86 million as of January 30, 2026. Its market cap has decreased by -31.14% in one year.
Market Cap
28.86M
Enterprise Value
27.19M
Revenue
4.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.43
Market Cap Chart
Since July 10, 2019, MustGrow Biologics's market cap has increased from 5.42M to 28.86M, an increase of 432.58%. That is a compound annual growth rate of 29.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 28.86M | 25.32% |
| Dec 31, 2025 | 23.03M | -42.23% |
| Dec 31, 2024 | 39.87M | -12.34% |
| Dec 29, 2023 | 45.48M | -62.58% |
| Dec 30, 2022 | 121.54M | -8.26% |
| Dec 31, 2021 | 132.48M | 326.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U.C.A. Aktiengesellschaft | 40.51M |
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.35M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |